课题基金 / 基金详情

The role of apoE from human monocyte in atherosclerosis

The role of apoE from human monocyte in atherosclerosis
人单核细胞apoE在动脉粥样硬化中的作用
批准号:
03671114
负责人:
TAKAGI Yasushi
金额:
$1.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1993

项目摘要

项目成果

TAKAGI Yasushi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Monocyte/macrophage plays an important role in developing atherosclerosis. Monocyte would growing form cell, increasing the intima of the vessel, that was atherosclerosis. MOnocyte/macrophage. Secreting apoE was considered the negative factor of developing atherosclerosis This project has a purpose of evaluation the relationship between the dose of secreting apoE and developing atherosclerosis.Human monocyte purified from peripheral blood by centtifugal and plastic adhesion technique was cultured with mediators, such as acetyl LDL and autologous platelet, for 5 days under 95% of O_2 and 5% of CO_2. ApoE in the supernatant of cultured media was measured by immunological method using specific anti-apoE antibody. Cholesterol and cholesterol ester in cultured monocyte/macrophage was measured by enzymatic method. In healthy volunteers.secreting apoE and intaking cholesterol in monocyte/macrophage had big differences between individuals. These results suspect that secreting apoE and stored cholesterol might be aspecific and sensitive markersfor suspecting the development of atherosclerosis in the future. The long term follow-up study should be needed to confirm the significance of secreting apoE measurement.We started to study the measuring significance of secreting apoE in clinical status. At first, we evaluate in diavetes mellitus (DM), because DM was very popular disease and we could get much blood from patient's peripheral vessel. We had many troubles in culturing monocyte/macrophage because of contaminating fungus and bacteria. We could not understand what factor affect these troubles. No laboratory markers, such as blood sugar, HbAlc, C-peptide, and/or urinary sugar did not have thedirect relationship tp the trouble, contamination. We kept going the study in DM.If we could, we would like to evaluate the secreting apoE significance in acute myocardial infarction and cerebral infarction, those were typocal clinical of atherosclerosis.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Miya, T., Takagi, Y., and Gomi, K.: "Platelet and atherosclerosis." Clinical News. 12. 33-38 (1991)
Miya, T.、Takagi, Y. 和 Gomi, K.:“血小板和动脉粥样硬化。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
宮,哲正・高木,康・五味,邦英: "血小板と動脈硬化" クリニカルニュース. 12. 33-38 (1991)
Miya、Tetsumasa、Takagi、Yasushi、Gomi、Kunihide:“血小板和动脉硬化”临床新闻。12. 33-38 (1991)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Stroke therapy using embryonic stem cells and bone marrow stromal cell-derived neuralstem cells
  • 批准号:
    20390382
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $12.31万
  • 财政年份:
    2008
  • 负责人:
    TAKAGI Yasushi
  • 依托单位:
Transplantation of primate embryonic stem cell-derived neural stem cell against brain ischemia
  • 批准号:
    18591588
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.57万
  • 财政年份:
    2006
  • 负责人:
    TAKAGI Yasushi
  • 依托单位:
The ratio of beta catenin to APC in tumor cell
  • 批准号:
    13672429
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.18万
  • 财政年份:
    2001
  • 负责人:
    TAKAGI Yasushi
  • 依托单位:
Serum CK isoenzyme - Gene analysis of hyperCK-BB patient -
  • 批准号:
    11672308
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.92万
  • 财政年份:
    1999
  • 负责人:
    TAKAGI Yasushi
  • 依托单位:
国内基金
海外基金
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
  • 批准号:
    82371651
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵栋
  • 依托单位:
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
  • 批准号:
    82371028
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵慧
  • 依托单位:
IL-4协同精氨酸优化种植初期巨噬细胞胞葬作用和成骨微环境的作用及机制研究
  • 批准号:
    82370923
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张文杰
  • 依托单位:
NPM1表观重塑巨噬细胞代谢及修复表型在心肌缺血损伤中的调控作用
  • 批准号:
    82371825
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    占贞贞
  • 依托单位: